Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Psychotic patients distinguished from controls while watching movie Alice in Wonderland

  • Clinical trial shows first treatment for ?emotional flatness? associated with schizophrenia

  • Food may be addictive: Food craving may be 'hard-wired' in the brain

  • Testosterone changes brain structures in female-to-male transsexuals

  • Cold weather associated with higher risk of severe heart attack

  • Cold weather linked to increased stroke risk in atrial fibrillation patients

  • How can we prevent suicide? Major study shows risk factors associated with depression

  • Scientists show how magnetic pulses change the brain in treatment for depressed patients

  • A single cocaine dose lowers perceptions of sadness and anger

  • Better signs could help reduce friction between motorists, bicyclists

  •